Briefcases -- Drugs -- ACTEMRA (tocilizumab) by Genentech USA, Inc. (Roche Group)

ACTEMRA (tocilizumab) by Genentech USA, Inc. (Roche Group)

Case Files
News
Committees
Request a Document
Request
Search Within Briefcase

Folders

  1. Media References
  2. FDA Regulatory Materials

Quick Access

  1. ACTEMRA (tocilizumab) STAT Report (March 28, 2013)
  2. ACTEMRA (tocilizumab) Letter to Healthcare Providers (October 2013)
  3. ACTEMRA (tocilizumab) 2 of 2 STAT News Article_"Failure to warn: An early warning system for drug risks falls flat" (June 6, 2017)
  4. ACTEMRA (tocilizumab) FDA Meeting Summary (June 26, 2008)
  5. ACTEMRA (tocilizumab) Rheumatology News_"Tocilizumab raises cholesterol, but not cardiovascular events" (published December 7, 2016)
  6. ACTEMRA (tocilizumab) 1 of 2 STAT News Article_Failure to warn: Hundreds died but nobody alerted patients" (June 5, 2017)
  7. ACTEMRA (tocilizumab) BLA Supplement Approval (May 22, 2017)
  8. ACTEMRA (tocilizumab) FDA Label (March 2017)